Drugs

Drug studies with the file the authority expects.

From the protocol to the tables. EU Clinical Trials Regulation and FDA IND on the same record, when the study needs both.

What a drug study keeps here

Protocol and amendment versions. Eligibility, visits, and endpoints. Adverse events with seriousness, causality, and expectedness. Safety reporting timed for CTIS or for an IND. Estimands when the analysis estimates a treatment effect. Listings, tables, and figures that name the snapshot they came from. SDTM and ADaM are in the target so an eCTD package can be produced without retyping the trial.

EU

Clinical Trials Regulation 536/2014, CTIS milestones, and SUSAR timing.

United States

IND safety, IRB approval, Form 1572, and financial disclosure sit on the same checklist engine.

The signature

A lock is a content-bound signature. A later edit makes that signature visibly invalid.

Bring us the protocol.

CAREPOI reads the study, configures ValidTrials, and the sites work in one record. The first conversation is about your protocol, not a software tour.

Request a conversation